| 摘要 |
As discussed above the present invention in a first aspect thereof relates to the use of a tetracycline, preferably minocycline, for manufacture of a pharmaceutical composition for treatment or prevention of a disorder selected from Parkinson's disease and related disorders, preferably Parkinson's disease. In a second aspect thereof the invention relates to a method for treating or prevention of a disorder selected from Parkinson's disease and related disorders in a patient in need thereof, which method includes administering the patient an effective dosage of a tetracycline, preferably minocycline. In a third aspect thereof the invention relates to the use of a tetracycline, preferably minocycline, as a neuro-protective agent in general.
|
